SGS expands testing capabilities at Glasgow facility
Bio/pharmaceutical analytical and bioanalytical contract solutions provider, SGS, has announced that it has invested £7.6 million in its facility in...
Bio/pharmaceutical analytical and bioanalytical contract solutions provider, SGS, has announced that it has invested £7.6 million in its facility in...
Global biotherapeutics leader CSL announced that it will proceed with a Phase 3 clinical trial for CSL112, the company’s novel...
Fresenius Kabi opened the extension of its production plant in Mihla, Germany, today with a festive dedication ceremony attended by...
GSK welcomes the launch of the UK Government’s Life Sciences Sector Deal, which builds on the Industrial Strategy published by...
GlaxoSmithKline plc announced that new data from a Phase III clinical study supports the safety and efficacy of Shingrix (Zoster...
WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company, offering end-to-end solutions for biologics discovery, development and manufacturing,...
LivaNova PLC, a market-leading medical technology company, announced it has entered into an agreement to acquire the remaining outstanding interests...
Bayer and Loxo Oncology, Inc., a biopharmaceutical company based in Stamford, Connecticut, US, announced updated clinical data from the larotrectinib...
PMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of PMC Group...
Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for OZEMPIC® (semaglutide)...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.